Full-year 2023 revenue reached $2,033.7 million, with Q4 revenue at $510.3 million. Adjusted EBITDA: Improved to 81.2% for the full year and 82.4% for Q4, a significant reduction from the previous year. Clover Health Investments Corp (NASDAQ:CLOV) released its 8-K filing, detailing the financial results for the fourth quarter and full year of 2023.